Outsourced Pharma Capacity Update Videos - Cell & Gene

1. Forge Biologics, A Member Of Ajinomoto Bio-Pharma Services, Capacity Update January 2025: Cell & Gene Therapy 1/30/2025

   See how Forge’s dedicated 200,000 sq. ft. facility, proprietary technologies, and specialized services provide expert AAV manufacturing to empower developers from discovery to delivery and every step in between.

2. Andelyn Biosciences Capacity Update January 2025: Cell & Gene Therapy 1/30/2025

   Here we introduce the structure and capabilities of our Laboratory Services group, a cornerstone of our commitment to excellence in pharmaceutical development.

3. Aldevron Capacity Update January 2025: Cell & Gene Therapy 1/30/2025

   In this session, you will discover how Alchemy technology utilizes a cell-free, enzymatic DNA manufacturing process that accelerates linDNA template production, allowing you to expedite your mRNA research and development pipeline.

4. Theragent Capacity Update October 2024: Cell & Gene Therapy 10/24/2024

   Our Arcadia, CA facilities provide cell therapy development, testing, manufacturing, a proprietary digital trial platform, and preclinical research through our Discovery Center.

5. Viralgen Capacity Update October 2024: Cell & Gene Therapy 10/24/2024

   Advance your rAAV gene therapy from concept to commercial scale, leveraging our world-leading expertise and capacity to bring life-changing treatments to patients in need.

6. WuXi Advanced Therapies Capacity Update October 2024: Cell & Gene Therapy 10/24/2024

   An update on our Philadelphia campus: comprehensive CGT services, from discovery to clinical production, with integrated bioanalytical testing to streamline timelines and reduce risks.

7. ElevateBio Capacity Update October 2024: Cell & Gene Therapy 10/24/2024

   Katie Jorgensen introduces ElevateBio BaseCamp's path to commercial readiness in cell therapy, highlighting key strategies for scaling from clinical to commercial manufacturing, with a focus on staffing, training, and preparation for 2025.

8. Advanced Medicine Partners Capacity Update October 2024: Cell & Gene Therapy 10/24/2024

   Gain insight into our unparalleled expertise as a leading CDMO in viral vectors, offering top-tier process development, analytical development, and manufacturing solutions.

9. Andelyn Biosciences Capacity Update October 2024: Cell & Gene Therapy 10/24/2024

   Discover our innovative DOE-based strategy for developing a scalable suspension platform to produce and purify AAV vectors, optimizing consistency, productivity, and quality across scales.

10. FUJIFILM Diosynth Biotechnologies Capacity Update October 2024: Cell & Gene Therapy 10/24/2024

    Here, we showcase our investment in cell therapy services and explore the innovative designs and expansions at the Thousand Oaks facility that will enhance GMP production capabilities.